Evidence map›Paper›PMID 34569937›Full record

ArticleeLife2021

Characterization and prediction of clinical pathways of vulnerability to psychosis through graph signal processing.

Corrado Sandini, Daniela Zöller, Maude Schneider, Anjali Tarun, Marco Armando, Barnaby Nelson, Paul G Amminger, Hok Pan Yuen, Connie Markulev, Monica R Schäffer and 16 more

Abstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Increasing participation of people with thought disorder in clinical research.European psychiatry : the journal of the Association of European Psychiatrists · 2026
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Corrado SandiniDevelopmental Imaging and Psychopathology Laboratory, University of Geneva School of Medicine, Geneva, Switzerland.ORCID https://orcid.org/0000-0003-2933-1607
Daniela ZöllerDevelopmental Imaging and Psychopathology Laboratory, University of Geneva School of Medicine, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-7049-0696
Maude SchneiderDevelopmental Imaging and Psychopathology Laboratory, University of Geneva School of Medicine, Geneva, Switzerland.ORCID http://orcid.org/0000-0001-7147-8915
Anjali TarunInstitute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Marco ArmandoDevelopmental Imaging and Psychopathology Laboratory, University of Geneva School of Medicine, Geneva, Switzerland.
Barnaby NelsonOrygen, Parkville, Australia.
Paul G AmmingerOrygen, Parkville, Australia.
Hok Pan YuenOrygen, Parkville, Australia.
Connie MarkulevOrygen, Parkville, Australia.
Monica R SchäfferThe Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.
Nilufar MossahebDepartment of Psychiatry and Psychotherapy, Clinical Division of Social Psychiatry, Medical University Vienna, Vienna, Austria.
Monika SchlögelhoferDepartment of Psychiatry and Psychotherapy, Clinical Division of Social Psychiatry, Medical University Vienna, Vienna, Austria.
Stefan SmesnyDepartment of Psychiatry and Psychotherapy, Clinical Division of Social Psychiatry, Medical University Vienna, Vienna, Austria.
Ian B HickieDepartment of Psychiatry, University Hospital Jena, Jena, Germany.
Gregor Emanuel BergerBrain and Mind Centre, University of Sydney, Sydney, Australia.
Eric Yh ChenChild and Adolescent Psychiatric Service of the Canton of Zurich, Zurich, Switzerland.
Lieuwe de HaanDepartment of Psychiatry, University of Hong Kong, Hong Kong, China.
Dorien H NiemanDepartment of Psychiatry, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Merete NordentoftPsychiatric Centre Bispebjerg, Copenhagen, Denmark.
Anita Riecher-RösslerUniversity of Basel, Basel, Switzerland.
Swapna VermaInstitute of Mental Health, Singapore, Singapore.
Andrew ThompsonOrygen, Parkville, Australia.
Alison Ruth YungOrygen, Parkville, Australia.
Patrick D McGorryOrygen, Parkville, Australia.
Dimitri Van De VilleInstitute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-2879-3861
Stephan EliezDevelopmental Imaging and Psychopathology Laboratory, University of Geneva School of Medicine, Geneva, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Causal interactions between specific psychiatric symptoms could contribute to the heterogenous clinical trajectories observed in early psychopathology. Current diagnostic approaches merge clinical manifestations that co-occur across subjects and could significantly hinder our understanding of clinical pathways connecting individual symptoms. Network analysis techniques have emerged as alternative approaches that could help shed light on the complex dynamics of early psychopathology. The present study attempts to address the two main limitations that have in our opinion hindered the application of network approaches in the clinical setting. Firstly, we show that a multi-layer network analysis approach, can move beyond a static view of psychopathology, by providing an intuitive characterization of the role of specific symptoms in contributing to clinical trajectories over time. Secondly, we show that a Graph-Signal-Processing approach, can exploit knowledge of longitudinal interactions between symptoms, to predict clinical trajectories at the level of the individual. We test our approaches in two independent samples of individuals with genetic and clinical vulnerability for developing psychosis. Novel network approaches can allow to embrace the dynamic complexity of early psychopathology and help pave the way towards a more a personalized approach to clinical care.

Indexed as

AdultFemaleHumansLongitudinal StudiesMalePrecision MedicinePsychotic Disorders22q11.2 deletion syndromeaffective pathwayhumanmedicinenetwork analysisschizophrenia

Identifiers

PMID34569937
PMCPMC8476129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.